Liz Parrish, founder and CEO of BioViva, delivers a compelling keynote on the revolutionary potential of gene therapy for human longevity and rejuvenation.

As one of the boldest voices in the longevity field and the first person to undergo experimental gene therapy for aging, Parrish shares her insights into how genetic interventions are ready to extend human healthspan.

Parrish challenges the status quo of medical research and advocates for faster translations of scientific advances, arguing that delayed access is costing millions of lives.